Discussion
diabetic, diabetes
DIABETES
Among people with diabetes, adherence to daily low-dose aspirin reduced U-TXM by 72%. This reduction was similar to reductions reported in a previous longitudinal daily aspirin intervention comparison in people with and without diabetes [The present study also investigated the level of suppression by time since taking aspirin. Among adherent participants taking their tablet > 12 h before their urine sample, the reduction in U-TXM (72%) and percentage achieving effective suppression (70%) were similar to those in the study overall. However, a limitation of the present study was that it did not include different dosing schedules. A randomized crossover trial in 24 diabetic participants found a somewhat greater reduction in mean U-TXM with 100 mg aspirin twice daily (80% reduction) than once daily (76% reduction; difference between regimens statistically significant at 